Haemonetics Corporation (NYSE:HAE) Shows Near-Term Pressure But Valuation Suggests Rebound
![]() |
Recent corporate updates tightened market focus while core cash generation and WMDST’s valuation classify Haemonetics as under-valued; momentum indicators, however, signal near-term downside pressure that could compress before any mean reversion. |









